BLUEBIRD BIO INC - COM (BLUE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2025

Type / Class
Equity / COM
Symbol
BLUE on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$97,908 0
2024 Q4 10,962 $97,908 -$31,938,116 $8.68 3
2024 Q3 61,789,889 $32,102,852 -$13,406,761 $0.52 133
2024 Q2 78,337,558 $77,005,822 -$30,131,260 $0.98 147
2024 Q1 102,552,658 $131,266,043 -$37,708,326 $1.28 154
2023 Q4 130,397,079 $179,947,111 +$45,457,701 $1.38 186
2023 Q3 89,532,454 $272,176,868 -$12,872,464 $3.04 165
2023 Q2 93,625,050 $308,015,892 -$9,999,146 $3.29 171
2023 Q1 97,207,233 $309,113,789 +$83,299,818 $3.18 172
2022 Q4 67,958,037 $470,260,405 +$18,502,261 $6.92 179
2022 Q3 65,587,091 $415,094,203 +$75,190,591 $6.33 151
2022 Q2 55,028,677 $227,911,037 -$29,041,166 $4.14 137
2022 Q1 61,990,594 $300,611,133 -$32,203,990 $4.85 159
2021 Q4 58,224,309 $581,745,577 +$42,465,959 $9.99 149
2021 Q3 51,605,867 $986,150,762 -$81,619,106 $19.11 174
2021 Q2 53,112,116 $1,698,350,058 +$42,959,872 $31.98 221
2021 Q1 51,848,790 $1,563,005,501 -$565,191,880 $30.15 210
2020 Q4 62,181,163 $2,690,654,040 -$65,671,775 $43.27 250
2020 Q3 64,379,566 $3,473,619,148 -$84,334,840 $53.95 269
2020 Q2 64,481,859 $3,936,264,424 +$367,756,283 $61.04 274
2020 Q1 58,270,673 $2,678,119,837 -$113,369,768 $45.96 233
2019 Q4 60,085,788 $5,272,566,932 -$360,433,519 $87.75 268
2019 Q3 63,909,838 $5,868,229,342 +$156,314,267 $91.82 235
2019 Q2 62,222,168 $7,914,245,524 +$129,226,910 $127.20 270
2019 Q1 62,326,221 $9,805,597,971 +$244,032,456 $157.33 282
2018 Q4 61,078,573 $6,058,905,131 +$247,459,592 $99.20 242
2018 Q3 58,044,073 $8,473,758,476 +$650,010,637 $146.00 285
2018 Q2 53,546,003 $8,404,252,298 +$117,845,526 $156.95 303
2018 Q1 52,701,425 $8,997,858,784 +$95,057,520 $170.75 304
2017 Q4 52,131,369 $9,283,570,334 +$313,712,020 $178.10 297
2017 Q3 50,244,790 $6,896,982,028 +$162,104,322 $137.35 239
2017 Q2 49,126,671 $5,160,489,255 +$295,046,604 $105.05 237
2017 Q1 46,595,044 $4,235,196,063 +$267,041,341 $90.90 206
2016 Q4 46,627,744 $2,877,069,385 +$109,416,500 $61.70 196
2016 Q3 44,587,112 $3,020,802,469 +$120,090,610 $67.78 198
2016 Q2 43,695,110 $1,891,593,236 +$132,687,661 $43.29 172
2016 Q1 40,544,660 $1,723,082,106 +$10,289,856 $42.50 182
2015 Q4 39,419,018 $2,531,547,824 +$115,784,211 $64.22 188
2015 Q3 36,602,024 $3,130,615,730 +$24,457,291 $85.55 191
2015 Q2 34,889,466 $5,872,673,076 +$601,323,211 $168.37 234
2015 Q1 31,524,393 $3,808,115,991 +$245,390,566 $120.77 210
2014 Q4 29,892,446 $2,741,974,965 +$588,838,558 $91.72 169
2014 Q3 23,571,432 $845,742,975 +$150,921,875 $35.88 122
2014 Q2 19,244,863 $742,268,972 +$58,563,758 $38.57 101
2014 Q1 18,096,309 $411,508,360 +$13,149,914 $22.74 79